twodimension
dipolarassist
rotat
reson
aid
acquir
immunodefici
syndrom
bamp
aminomethyl
pyrrol
ca
cymbidium
sp
agglutinin
cpma
crosspolarizationmag
angl
spin
cvn
cyanovirinn
egta
ethylen
glycolbi
ether
n
n
n
n
tetraacet
acid
elisa
enzymelink
immunosorb
assay
gal
dgalactos
glc
dglucos
glcnac
nacetyldglucosamin
gna
galanthu
nivali
agglutinin
hcv
hepat
c
viru
hea
epipacti
helleborin
agglutinin
hha
hippeastrum
hybrid
agglutinin
hiv
human
immunodefici
viru
icd
induc
circular
dichroism
carbohydr
regul
varieti
biochem
pathway
diseas
process
includ
protein
fold
fertil
embryogenesi
neuron
develop
cell
prolifer
microbi
viral
infect
cancer
metastasi
coupl
advanc
understand
function
carbohydr
biolog
patholog
process
import
carbohydratebind
molecul
rapidli
grow
chemic
tool
glycobiolog
extens
use
carbohydratebind
molecul
lectin
defin
protein
nonimmun
origin
bind
specif
carbohydr
without
modifi
prove
extrem
use
tool
isol
character
glycoprotein
also
detect
dynam
spatiotempor
chang
associ
patholog
process
addit
sever
lectin
deriv
prokaryot
plant
invertebr
vertebr
speci
bind
specif
mannos
galactos
nacetylglucosamin
glcnac
found
inhibit
infect
envelop
virus
human
immunodefici
viru
hiv
hepat
c
viru
hcv
repres
lectin
antivir
activ
mannosespecif
agglutinin
galanthu
nivali
gna
hippeastrum
hybrid
hha
cymbidium
sp
ca
narcissu
pseudonarcissu
npa
epipacti
helleborin
hea
listera
ovata
loa
glcnacspecif
agglutinin
urtica
dioica
uda
cyanobacteriumderiv
lectin
cvn
lectin
show
dual
mode
antivir
action
blockag
viru
entri
trigger
action
immun
system
expos
cryptic
immunogen
epitop
viru
surfac
discoveri
uniqu
antihiv
properti
lectin
never
observ
exist
chemotherapeut
spur
intens
studi
lectin
therapeut
agent
lectin
great
valu
possibl
drug
candid
well
chemic
tool
glycobiolog
research
sever
disadvantag
due
natur
protein
first
largescal
product
protein
gener
costli
timeconsum
rel
low
chemic
stabil
may
problemat
long
storag
therapeut
viewpoint
bioavail
protein
like
poor
concern
also
rais
unfavor
biolog
properti
lectin
immunogen
inflammatori
activ
cellular
toxic
mitogen
stimul
human
peripher
lymphocyt
cell
hemagglutin
human
red
blood
cell
situat
nonprotein
smallsiz
molecul
carbohydratebind
properti
recent
attract
great
deal
attent
altern
lectin
protein
structur
sinc
small
molecul
prepar
reliabl
quantiti
easili
tune
structur
optim
lectin
mimic
may
potenti
benefit
research
tool
drug
candid
lectin
mimic
synthet
origin
develop
progress
recent
year
basi
moleculardesign
principl
synthet
lectin
mimic
may
divid
roughli
two
group
boron
aciddepend
boron
acidindepend
lectin
mimic
former
group
possess
boron
acid
motif
form
tight
revers
coval
bond
group
carbohydr
boron
acid
low
affin
common
carbohydr
physiolog
ph
affin
enhanc
introduct
neighbor
function
group
andor
use
two
boron
acid
motif
proper
align
contrast
boron
acidindepend
lectin
mimic
reli
sole
noncoval
interact
bind
carbohydr
type
lectin
mimic
intens
develop
field
supramolecular
chemistri
repres
molecular
architectur
includ
tripodand
cagetyp
incorpor
respect
hydrophil
hydrophob
surfac
hydrogen
bond
chp
interact
weak
hydrogen
bond
occur
ch
group
aromat
ring
carbohydr
combin
noncoval
interact
collect
realiz
threedimension
recognit
carbohydr
articl
outlin
design
concept
molecular
architectur
carbohydratebind
properti
synthet
lectin
mimic
use
repres
exampl
discuss
therapeut
potenti
review
recent
attempt
develop
antivir
antimicrobi
agent
use
architectur
also
focu
natur
occur
lectin
mimic
pradimicin
prm
benanomicin
class
nonprotein
natur
product
ctype
lectinlik
properti
abl
recogn
dmannopyranosid
man
presenc
ca
ion
recent
investig
reveal
interest
similar
molecular
architectur
natur
product
tripodtyp
lectin
mimic
moreov
accumul
evid
suggest
uniqu
antimicrobi
profil
differ
major
class
antibiot
exhibit
antihiv
activ
manner
similar
lectin
emerg
concept
molecular
basi
carbohydr
recognit
therapeut
potenti
natur
occur
lectin
mimic
also
describ
boron
aciddepend
lectin
mimic
contain
one
boron
acid
moieti
respons
carbohydr
bind
boron
acid
act
lewi
acid
empti
porbit
boron
presenc
lewi
base
hydroxyl
group
interconvers
sp
sp
hybrid
readili
occur
aqueou
media
water
molecul
revers
add
neutral
trigon
form
boron
acid
produc
anion
tetrahedr
form
ii
releas
one
proton
scheme
alkalin
ph
rang
ph
diol
react
tetrahedr
form
ii
give
stabl
cyclic
boron
ester
iv
gener
affin
boron
acid
diol
carbohydr
follow
hand
boron
acid
exist
predomin
trigon
form
neutral
ph
rang
result
reaction
diol
produc
chemic
unstabl
adduct
iii
readili
hydrolyz
therefor
high
ph
gener
requir
order
favor
equilibrium
toward
cyclic
boron
ester
iv
realiz
arylboron
aciddiol
associ
neutral
ph
sever
attempt
made
stabil
adduct
one
promis
strategi
introduct
dialkylaminomethyl
group
ortho
posit
arylboron
acid
scheme
coval
append
amino
group
facilit
format
boron
ester
acceler
arylboron
aciddiol
associ
direct
bn
coordin
solventinsert
mechan
recent
investig
xray
crystallographi
bnmr
comput
analysi
support
latter
mechan
predomin
protic
solvent
use
molecular
architectur
key
structur
number
boron
aciddepend
lectin
mimic
report
major
work
direct
toward
develop
molecular
sensor
monitor
blood
dglucos
key
compon
insulinreleas
implant
diabet
patient
earli
landmark
studi
shinkai
cowork
develop
carbohydratebas
photoinduc
electrontransf
sensor
fig
compound
bound
carbohydr
neutral
ph
ph
show
increas
fluoresc
suppress
photoinduc
electron
transfer
pet
tertiari
amino
group
anthracenyl
group
upon
bind
carbohydr
bind
select
dglucos
poor
order
select
dfructos
dallos
dgalactos
dglucos
ethylen
glycol
compound
exhibit
bind
prefer
dglucos
order
select
dglucos
dallos
dfructos
dgalactos
ethylen
glycol
select
dglucos
explain
spatial
disposit
two
boron
acid
moieti
two
inwardli
face
boron
acid
moieti
perfectli
space
align
two
pair
diol
group
group
use
fluoresc
report
system
wang
cowork
develop
seri
dimer
analogu
fig
three
dimer
differ
linker
compound
show
highest
select
dglucos
tabl
suggest
linker
offer
appropri
orient
distanc
two
boron
acid
moieti
bind
dglucos
although
affin
dglucos
three
time
lower
compound
repres
enhanc
select
dglucos
dfructos
base
result
addit
three
deriv
electronwithdraw
group
gener
enhanc
carbohydr
affin
arylboron
acid
test
affin
select
carbohydr
although
introduct
cyano
nitro
group
enhanc
affin
dglucos
effect
signific
bind
dfructos
dgalactos
result
select
dglucos
lower
parent
compound
fluorosubstitut
deriv
inferior
affin
select
although
substitu
effect
carbohydr
select
arylboron
acid
hard
predict
interest
simpl
modif
aryl
group
chang
bind
prefer
carbohydr
introduct
chiral
pet
sensor
success
perform
shinkai
cowork
sensor
r
binaphthyl
moieti
chiral
fluorophor
build
block
discrimin
dglucos
lglucos
fig
maximum
increas
fluoresc
intens
observ
upon
bind
dglucos
wherea
lglucos
induc
increas
competit
experi
show
abil
recogn
dglucos
select
presenc
lglucos
recent
exampl
pet
sensor
use
chiral
unit
r
enantiom
contain
ethanamin
respect
bind
dglucos
caus
signific
increas
fluoresc
intens
wherea
smaller
chang
fluoresc
observ
case
studi
clearli
demonstr
select
boron
aciddepend
lectin
mimic
fine
tune
toward
one
optic
isom
carbohydr
addit
glucos
sensor
chemic
probe
carbohydr
chain
also
report
one
exampl
fluoresc
probe
sialyl
lewi
x
sle
x
develop
wang
cowork
fig
tetrasaccharid
sle
x
wellknown
cellsurfac
carbohydr
antigen
associ
develop
progress
mani
type
cancer
probe
sle
x
therefor
promis
diagnost
agent
cancer
compound
show
strong
fluoresc
enhanc
upon
bind
sle
x
mixtur
methanol
phosphat
buffer
ph
moreov
found
fluoresc
label
cell
express
high
level
sle
x
stain
neither
cell
express
lewi
cell
lack
fucosyl
antigen
use
uniqu
fluoresc
sle
x
probe
matrixassist
laser
desorptionion
mass
spectrometri
maldim
base
imag
cancer
tissu
perform
target
imag
mass
spectrometri
tim
power
method
imag
histolog
analysi
allow
spatial
visual
molecul
interest
directli
tissu
section
use
laserreact
photocleav
molecular
tag
attach
affin
molecul
wang
cowork
synthes
conjug
molecul
tritylbas
tag
tim
analysi
cancer
tissu
high
level
sle
x
perform
tumor
region
express
sle
x
success
detect
imag
suggest
msbase
imag
cancer
tissu
use
lectin
mimicbas
probe
feasibl
fig
probe
sialyl
lewi
x
although
odialkylaminomethyl
arylboron
acid
long
stood
establish
standard
design
boron
aciddepend
lectin
mimic
hall
cowork
subsequ
introduc
ohydroxymethyl
phenylboron
acid
benzoboroxol
promis
altern
benzoboroxol
consid
exist
cyclic
dehydr
boronophthalid
form
scheme
unusu
small
cbo
dihedr
angl
facilit
product
anion
boron
ester
diol
even
neutral
ph
open
cone
angl
result
tetrahedr
structur
boron
ester
format
also
entrop
favor
simpl
phenylboron
acid
requir
extern
hydroxyl
ligand
form
anion
tetrahedr
complex
scheme
import
interest
featur
capabl
bind
pyranos
form
carbohydr
neutral
water
sever
line
evid
suggest
carbohydr
bind
boron
acid
includ
odialkylaminomethyl
arylboron
acid
weakli
popul
furanos
form
pyranos
form
contrast
shown
bind
hexopyranosid
dglucos
dgalactos
dmannos
dfucos
weak
encourag
affin
tabl
ii
although
exact
mode
complex
fulli
understood
rel
high
lewi
acid
strain
cyclic
structur
thought
possibl
contribut
factor
except
pyranosidebind
behavior
take
advantag
pyranosidebind
capabl
hall
cowork
develop
watersolubl
receptor
fig
thomsenfriedenreich
tf
disaccharid
import
tumorassoci
carbohydr
antigen
present
cancer
design
receptor
base
assumpt
two
unit
benzoboroxol
would
bind
two
diol
unit
disaccharid
peptid
backbon
could
involv
hydrogen
bond
chp
interact
disaccharid
tri
ethylen
glycol
compon
introduc
increas
water
solubl
librari
exampl
differ
peptid
backbon
prepar
solidphas
peptid
synthesi
screen
bind
tf
antigen
disaccharid
use
competit
enzymelink
immunosorb
assay
elisa
potent
receptor
show
ic
mm
compound
electronrich
pmethoxyphenylalanin
compon
furan
favor
chp
interact
hydrogen
atom
carbohydr
ring
import
benzoboroxol
moieti
confirm
weak
affin
control
compound
ic
use
lectin
recent
propos
novel
promis
approach
antivir
chemotherapi
lectin
exhibit
antivir
activ
rang
virus
hiv
hcv
coronaviru
influenza
viru
antivir
effect
lectin
ascrib
specif
bind
carbohydr
chain
glycan
viral
envelop
well
known
sever
protein
viral
envelop
dens
glycosyl
exampl
envelop
glycoprotein
possess
averag
nlink
glycan
constitut
half
molecular
weight
molecul
glycan
envelop
play
crucial
role
enabl
effici
entri
hiv
suscept
target
cell
bind
lectin
glycan
thu
inhibit
effici
function
envelop
molecul
viral
entri
anoth
import
role
envelop
glycan
hide
highli
immunogen
epitop
immun
system
host
glycan
shield
neutral
antibodi
respons
elicit
result
immun
system
abl
suppress
hiv
howev
glycan
progress
delet
longterm
exposur
hiv
lectin
mutat
hiv
weaken
glycan
shield
trigger
product
neutral
antibodi
immunogen
epitop
previous
hidden
despit
promis
dual
mode
antihiv
action
lectin
concern
regard
therapeut
use
rais
account
unaccept
high
cost
largescal
product
low
chemic
stabil
unfavor
immunogen
respons
investig
therefor
ongo
identifi
lectin
mimic
high
synthet
access
high
chemic
stabil
boron
aciddepend
lectin
mimic
undoubtedli
potenti
candid
exhibit
lectinlik
antihiv
activ
first
attempt
evalu
antivir
activ
smallsiz
boron
acid
deriv
made
mcguigan
cowork
initi
screen
divers
rang
ortho
meta
parasubstitut
monophenylboron
acid
test
antivir
activ
broad
rang
virus
includ
varicella
zoster
viru
influenza
viru
fig
unfortun
none
compound
show
antivir
activ
subtox
concentr
bound
research
group
therefor
perform
second
screen
use
librari
bisphenylboron
acid
varieti
linker
fig
although
compound
potenti
bind
two
set
diol
group
glycan
surfac
plasmon
reson
spr
experi
reveal
none
bisphenylboron
acid
bound
even
mm
obvious
compound
lack
abil
inhibit
viru
replic
although
result
disappoint
data
valuabl
futur
research
aim
design
smallsiz
phenylboron
acid
deriv
antivir
activ
hand
kiser
cowork
success
develop
watersolubl
polym
phenylboron
acid
promis
antihiv
agent
fig
advantag
use
polym
structur
multival
interact
realiz
multipli
link
boron
acid
group
polym
abund
glycan
viral
envelop
multival
interact
compens
weak
bind
affin
ligand
entrop
advantag
steric
stabil
often
found
natur
system
includ
carbohydratelectin
interact
moreov
util
benzoboroxol
boron
acid
compon
bind
nonreduc
carbohydr
methyl
admannopyranosid
methyl
adgalactopyranosid
physiolog
ph
alreadi
describ
use
benzoboroxol
quit
ration
glycan
high
mannosetyp
oligosaccharid
contain
three
termin
nonreduc
mannos
residu
complextyp
oligosaccharid
termin
extent
nonreduc
galactos
group
fig
base
molecular
design
concept
research
group
kisher
synthes
benzoboroxolefunction
oligom
polym
compound
boron
acidderiv
monom
incorpor
differ
feed
ratio
linear
backbon
spr
experi
reveal
mol
function
oligom
show
higher
affin
simpl
benzoboroxol
hand
bind
detect
oligom
lack
benzoboroxol
compon
concentr
indic
multival
interact
benzoboroxol
group
glycan
respons
signific
affin
compound
antivir
activ
evalu
polym
compound
polym
larger
molecular
weight
decreas
cytotox
prevent
cellular
uptak
mol
function
polym
show
slightli
higher
activ
ec
mm
control
polym
without
benzoboroxol
group
ec
mm
increas
degre
function
markedli
decreas
ec
valu
mol
function
polym
exhibit
strong
activ
ec
mm
compar
natur
lectin
cvn
kisher
group
also
develop
second
gener
benzoboroxolefunction
polym
mol
acid
incorpor
neg
charg
sulfon
group
expect
increas
aqueou
solubl
polym
neutral
ph
also
increas
bind
affin
electrostat
interact
posit
charg
peptid
fragment
loop
fact
almost
increas
aqueou
solubl
observ
incorpor
methylpropanesulfon
acid
moieti
compound
show
enhanc
activ
ec
nm
physic
mixtur
demonstr
asn
asn
signific
increas
activ
suggest
simultan
ionic
coval
interact
possibl
contribut
observ
synergist
improv
antivir
activ
moreov
biocompat
evalu
human
vagin
tissu
suggest
like
nontox
studi
provid
first
exampl
boron
aciddepend
lectin
mimic
antihiv
activ
demonstr
polym
promis
candid
develop
microbicid
contrast
boron
aciddepend
lectin
mimic
util
nonnatur
coval
interact
carbohydr
bind
boron
acidindepend
lectin
mimic
bind
carbohydr
natur
noncoval
interact
receptor
gener
realiz
carbohydr
recognit
combin
hydrogen
bond
chp
interact
metal
coordin
manner
similar
natur
lectin
characterist
boron
acidindepend
lectin
mimic
often
refer
biomimet
carbohydr
receptor
imit
bind
motif
observ
crystal
structur
lectincarbohydr
complex
number
boron
acidindepend
lectin
mimic
design
among
section
focus
tripodtyp
cagetyp
architectur
review
design
concept
carbohydratebind
properti
repres
compound
tripodtyp
receptor
principl
incorpor
three
hydrophob
unit
interconnect
aren
spacer
fig
initi
studi
demonstr
tripodtyp
architectur
effect
carbohydr
recognit
subtl
structur
variat
lead
remark
chang
receptor
properti
sinc
discoveri
mazik
group
perform
systemat
studi
use
tripod
architectur
found
varieti
function
group
heteroaromat
guanidinium
carboxyl
crown
ether
hydroxi
amid
oximebas
group
suitabl
hydrophil
unit
tripodtyp
receptor
report
mazik
group
also
shown
fig
receptor
contain
respect
primari
amid
amino
hydroxyl
group
instead
one
aminopyridin
unit
function
group
incorpor
analogu
side
chain
asn
gln
ly
ser
often
observ
carbohydratebind
motif
natur
lectin
bind
profil
amino
hydroxyl
group
respect
almost
similar
parent
compound
signific
enhanc
affin
octbglc
observ
two
primari
amid
group
tabl
iii
receptor
contain
imidazol
indol
ring
mimic
side
chain
trp
respect
also
test
bind
octbglc
octaglc
octbgal
mark
enhanc
bind
glycosid
observ
compound
hnmr
analysi
suggest
chp
interact
might
contribut
significantli
complex
octbglc
hand
introduct
unnatur
phenanthrolin
ring
hydrophil
unit
shown
particularli
effect
bind
octband
octaglc
molecularmodel
calcul
suggest
bind
pocket
correct
shape
size
encapsul
glucopyranosid
base
observ
phenanthrolin
imidazol
indol
ring
valuabl
build
block
hydrophil
unit
new
seri
receptor
contain
two
unit
build
block
design
although
affin
respect
one
two
phenanthrolin
unit
octbglc
octaglc
larg
calcul
chloroform
titrat
experi
sochloroform
reveal
superior
bglc
binder
k
k
result
indic
incorpor
second
phenanthrolin
unit
caus
enhanc
bind
affin
receptor
hand
signific
chang
bind
prefer
observ
contain
respect
two
imidazol
indol
unit
wherea
affin
receptor
octbglc
markedli
decreas
compar
respect
one
imidazol
indol
unit
display
high
level
affin
toward
octbgal
bind
select
octbgal
increas
alkyl
side
chain
val
leu
hydrophil
unit
respect
bind
affin
octbgal
slightli
higher
octbglc
van
der
waal
contact
branch
alkyl
group
glycosid
probabl
contribut
bind
capac
effect
receptor
octbgal
report
date
compound
two
unit
receptor
display
select
octbgal
octbglc
octaglc
affin
octbgal
extrem
potent
addit
tripodtyp
receptor
monosaccharid
mazik
group
develop
tetrapodtyp
receptor
fig
combin
dimesitylmethan
scaffold
four
aminopyridin
unit
expect
provid
caviti
suitabl
disaccharid
inde
receptor
exhibit
strong
bind
prefer
ndodecyl
bmaltosid
k
octbglc
k
k
chloroform
indic
rel
larg
architectur
fit
well
disaccharid
structur
roelen
cowork
develop
seri
pyrrol
tripod
receptor
use
triethylbenzen
scaffold
repres
shown
fig
receptor
evalu
set
noctyl
glycosid
biolog
relev
monosaccharid
includ
glc
gal
man
glcnac
roelen
group
assess
bind
affin
receptor
use
origin
paramet
bc
intrins
median
bind
concentr
descriptor
defin
total
concentr
receptor
necessari
bind
ligand
fraction
bound
receptor
zero
bc
valu
view
global
dissoci
constant
chemic
system
involv
number
complex
speci
complet
differ
acet
substitu
posit
pyrrol
receptor
show
strike
affin
octbman
strong
evalu
chloroform
titrat
experi
acetonitril
reveal
affin
octbman
almost
one
order
magnitud
greater
glycosid
nmr
experiment
data
combin
molecularmodel
fig
tripodtyp
boron
acidindepend
lectin
mimic
calcul
suggest
notabl
select
octbman
deriv
conform
restrict
induc
cyclic
acet
substitu
pyrrol
unit
result
narrow
bindingcleft
fit
preferenti
octbman
base
promis
result
roelen
group
develop
new
gener
manselect
receptor
incorpor
chiral
unit
receptor
display
substanti
affin
select
octaand
octbman
respect
replac
diamin
correspond
enantiom
decreas
affin
select
indic
chiral
receptor
play
key
role
determin
recognit
properti
receptor
regard
affin
select
effect
man
receptor
report
date
miller
cowork
gener
novel
class
tripodtyp
receptor
cyclohexan
scaffold
fig
achiev
conform
restrict
receptor
three
pyridin
quinolin
ring
directli
attach
cyclohexan
ring
h
nmr
uv
fluoresc
titrat
experi
demonstr
compound
strongli
bound
noctyl
glycosid
chloroform
even
polar
solvent
methanol
tabl
v
noteworthi
display
highest
bind
affin
report
date
octaglc
chloroform
retain
micromolar
rang
affin
methanol
result
indic
cyclohexan
ring
also
serv
effect
scaffold
design
tripodtyp
receptor
anoth
repres
architectur
boron
acidindepend
lectin
mimic
cage
type
consist
two
parallel
aromat
surfac
held
apart
hydrophil
group
fig
carbohydr
fulli
enclos
architectur
roof
floor
aromat
ring
provid
apolar
surfac
chp
interact
polar
pillar
hydrophil
unit
capabl
hydrogen
bond
carbohydr
structur
featur
cagetyp
receptor
specif
recogn
carbohydr
bglc
bglcnac
bear
allequatori
array
polar
function
allaxi
array
hydrophob
ch
group
pioneer
studi
davi
cowork
construct
prototyp
two
biphenyl
eight
isophthalamid
group
fig
molecular
model
suggest
caviti
creat
architectur
suffici
larg
accept
bglc
molecul
make
six
intermolecular
hydrogen
bond
sever
chp
interact
predict
confirm
bind
studi
employ
fluorescencetitr
experi
chloroform
receptor
bound
octbglc
substanti
affin
k
reason
select
octaglc
k
octbgal
k
moreov
nmr
experi
reveal
capabl
bind
octbglc
k
even
presenc
methanol
cdcl
cd
oh
davi
group
also
develop
extend
variant
compound
select
receptor
disaccharid
allequatori
array
polar
function
roelen
cowork
also
report
cagetyp
receptor
incorpor
aminopyrrol
group
fig
activ
organ
solvent
roof
floor
construct
extens
employ
core
scaffold
tripodtyp
receptor
alreadi
discuss
although
bind
caviti
smaller
rel
davi
receptor
compound
capabl
enclos
octbglc
k
chloroform
moreov
compound
found
bind
either
octaglc
isom
octgal
octman
indic
architectur
also
effect
recognit
carbohydr
allequatori
array
polar
function
base
promis
result
earli
work
davi
group
investig
effect
cage
architectur
aqueou
media
success
develop
watersolubl
variant
compound
fig
tricarboxyl
group
instal
hydrophil
compon
bind
properti
panel
carbohydr
thoroughli
examin
tabl
vi
accord
bind
prefer
organ
solvent
compound
display
substanti
affin
methyl
bdglucopyranosid
mebglc
water
k
howev
found
methyl
bdglucopyranosid
mebglcnac
better
target
k
affin
compound
mebglcnac
compar
natur
lectin
wheatgerm
agglutinin
wga
k
classic
use
bind
glcnac
residu
also
noteworthi
far
discriminatori
wga
wherea
wga
exhibit
signific
bind
sever
sugar
includ
glcnac
meaglcnac
nacetylneuramin
acid
n
n
diacetyldchitobios
affin
carbohydr
one
order
magnitud
weaker
mebglcnac
sinc
bglcnac
attach
hydroxyl
group
serin
threonin
common
posttransl
modif
protein
bind
experi
glycopeptid
contain
glcnac
residu
also
conduct
use
fig
base
sequenc
glcnaclink
casein
kinas
ii
although
extend
receptor
success
discrimin
noctyl
bcellobios
monosaccharid
disaccharid
chloroform
caviti
rel
flexibl
architectur
tendenc
collaps
aqueou
solut
hydrophob
contact
aromat
ring
roof
floor
avoid
phenomenon
davi
group
employ
metaterphenyl
structur
place
paraterphenyl
group
incorpor
fifth
isophthalamid
spacer
result
rigid
variant
fig
bear
carboxyl
group
shown
bind
cellobios
k
methyl
bcellobiosid
k
good
affin
aqueou
solut
tabl
vii
reliabl
k
valu
least
two
method
use
carbohydr
show
moder
affin
xylobios
k
n
n
diacetylchitobios
k
also
allequatori
disaccharid
weak
bind
detect
monosaccharid
disaccharid
k
interestingli
compound
distinguish
cellobios
lactos
structur
differ
one
asymmetr
center
subsequ
work
interest
hybrid
molecul
gener
new
watersolubl
receptor
fig
two
isophthalamid
spacer
replac
two
aminomethyl
pyrrol
bamp
spacer
isophthalamid
bamp
spacer
similar
length
differ
hydrogenbond
characterist
isophthalamid
spacer
two
set
amid
hydrogen
amid
carbonyl
group
act
hydrogenbond
donor
acceptor
respect
hand
bamp
spacer
contain
one
pyrrol
ring
hydrogenbond
donor
two
amino
group
act
either
donor
acceptor
depend
ph
solut
h
nmr
titrat
experi
basic
condit
pd
demonstr
affin
dglucos
k
twice
high
k
howev
bound
weakli
mebglc
k
glcnac
k
contrast
k
mebglc
k
glcnac
although
bind
test
neutral
condit
perform
solubl
problem
studi
suggest
select
among
allequatori
carbohydr
tune
though
modif
hydrogenbond
properti
cagetyp
receptor
alreadi
discuss
affin
select
cagetyp
receptor
carbohydr
almost
compar
natur
lectin
regard
cagetyp
receptor
often
call
synthet
lectin
sinc
synthet
lectin
superior
natur
lectin
term
chemic
stabil
synthet
access
eas
structur
modif
great
potenti
applic
glycobiolog
research
coupl
success
develop
tripodtyp
cagetyp
lectin
mimic
biomed
applic
begun
explor
consid
applic
antihiv
antimicrobi
therapi
would
desir
design
receptor
capabl
bind
man
main
compon
high
mannosetyp
oligosaccharid
hiv
envelop
cellwal
mannan
pathogen
yeast
bacteria
respect
cagetyp
receptor
unlik
use
applic
antihiv
antimicrobi
agent
weak
prefer
man
hand
sever
tripodtyp
receptor
shown
bind
man
organ
solvent
although
none
tripodtyp
receptor
thu
far
report
bind
carbohydr
aqueou
media
tripodtyp
architectur
advantag
regard
simplic
structur
allow
easi
prepar
librari
compound
systemat
studi
exploit
advantag
attempt
develop
tripodtyp
receptor
antihiv
antimicrobi
activ
recent
made
cowork
synthes
librari
tripodtyp
compound
evalu
antihiv
activ
librari
classifi
three
group
monom
fig
dimer
fig
trimer
fig
motif
incorpor
two
aromat
amino
acid
compon
phe
tyr
trp
triazin
motif
consid
tripodtyp
architectur
ring
core
scaffold
amino
acid
amin
group
act
hydrophil
compon
carboxyl
group
amino
acid
residu
also
crucial
increas
water
solubl
compound
dimer
trimer
design
base
assumpt
multival
interact
realiz
two
three
triazin
motif
glycan
viral
envelop
antihiv
activ
compound
evalu
inhibitori
activ
iii
b
rod
replic
cem
tcell
cultur
tabl
viii
valu
mm
hand
correspond
dimer
exhibit
low
antivir
activ
show
much
lower
amplitud
bind
bind
correspond
inact
monom
bare
detect
strong
correl
mono
di
trimer
antivir
activ
bind
affin
possibl
indic
antihiv
activ
tripodtyp
compound
ascrib
bind
certain
level
multival
interact
requir
show
antivir
bind
activ
one
remain
question
whether
observ
affin
due
bind
glycan
polyanion
compound
interact
protein
area
posit
charg
loop
addit
antihiv
activ
compound
seem
still
modest
compar
activ
natur
lectin
exampl
report
ec
valu
cvn
iii
b
rod
mm
respect
thu
three
order
magnitud
lower
nevertheless
studi
provid
strong
evid
antihiv
drug
discoveri
base
tripodtyp
architectur
viabl
approach
work
roelen
cowork
explor
potenti
tripodtyp
receptor
antimicrobi
agent
alreadi
describ
roelen
group
develop
famili
aminopyrrol
tripodtyp
compound
prove
effect
receptor
man
polar
organ
solvent
pradimicin
benanomicin
see
later
section
smallsiz
man
receptor
occur
natur
report
show
potent
antimicrobi
activ
wide
varieti
fungi
yeast
includ
clinic
import
pathogen
bind
mannan
cell
wall
focus
similar
manbind
properti
aminopyrrol
tripodtyp
compound
pradimicinrel
natur
product
roelen
group
perform
first
investig
antimicrobi
activ
aminopyrrol
tripodtyp
receptor
preliminari
screen
progenitor
famili
compound
effect
man
receptor
test
antimicrobi
activ
candida
tropicali
pichia
norvegensi
prototheca
wickerhamii
prototheca
zopfii
tabl
ix
compound
shown
inhibit
markedli
growth
four
microorgan
particular
minimum
inhibitori
concentr
mic
valu
compar
wellknown
antibiot
amphotericin
b
ketoconazol
structur
segment
fig
compound
less
activ
inact
indic
structur
compon
essenti
antimicrobi
activ
analogu
also
prepar
repres
exampl
shown
fig
antimicrobi
assay
use
varieti
yeast
yeastlik
microorgan
reveal
none
modif
includ
introduct
function
group
pyrrol
ring
variat
substitut
pattern
benzen
platform
enhanc
activ
parent
compound
tabl
x
bind
affin
compound
octaman
also
evalu
acetonitril
although
affin
may
reflect
bind
mannan
water
broad
correl
detect
antimicrobi
activ
manbind
affin
compound
without
antimicrobi
activ
lack
manbind
abil
wherea
compound
antimicrobi
activ
show
detect
bind
man
howev
perfect
correl
obtain
basi
result
roelen
cowork
propos
interest
hypothesi
man
bind
tripodtyp
compound
would
facilit
approach
microbi
cell
would
trigger
process
would
subsequ
involv
penetr
across
membran
cytoplasm
compound
might
exert
antimicrobi
activ
interact
specif
target
although
research
necessari
valid
hypothesi
pioneer
studi
emphas
promis
potenti
tripodtyp
carbohydr
receptor
antimicrobi
agent
novel
mode
action
number
public
describ
synthet
lectin
mimic
natur
product
possess
carbohydratebind
abil
report
pradimicin
prm
benanomicin
famili
natur
occur
lectin
mimic
nonpeptid
skeleton
three
prm
prma
b
c
two
benanomicin
benanomicin
b
first
isol
actinomycet
potenti
antibiot
oki
kondo
group
respect
interestingli
compound
found
share
common
aglycon
name
benzo
naphthacenequinon
differ
glycon
compon
fig
sinc
benanomicin
b
shown
prmc
model
candida
albican
cryptococcu
neoforman
aspergillu
fumigatu
tabl
xi
xii
list
vitro
vivo
antimicrobi
profil
prma
sinc
crossresist
antimicrobi
agent
amphotericin
b
ketoconazol
famili
compound
chemic
function
differ
major
class
antimicrobi
agent
initi
biochem
studi
use
c
albican
found
prma
caus
k
leakag
cell
bind
outer
surfac
c
albican
cell
ca
manner
absorpt
prma
c
albican
cell
found
origin
bind
mannan
yeast
cell
wall
result
collect
suggest
antimicrobi
action
prma
associ
alter
membran
permeabl
bind
cellwal
mannan
put
mechan
explain
well
fact
prma
induc
k
leakag
human
erythrocyt
mammalian
cell
presenc
ca
ion
structuremicrobi
activ
relationship
prma
also
thoroughli
examin
use
natur
occur
congen
artifici
deriv
fig
replac
dala
compon
lamino
acid
includ
lala
abolish
antimicrobi
activ
hand
daaminobutano
acid
dphe
dasp
acid
dli
gli
dser
deriv
retain
activ
indic
stereochemistri
posit
crucial
antimicrobi
action
prma
side
chain
dala
play
margin
role
amid
hydrogen
posit
seem
import
complet
loss
activ
observ
sarcosin
nmethylglycin
dpro
deriv
role
carboxyl
group
posit
also
examin
use
ester
amid
deriv
wherea
ester
butyl
amid
dipeptidyl
deriv
show
much
diminish
activ
amid
nmethylamid
n
ndimethylamid
deriv
effect
prma
observ
suggest
carboxyl
group
posit
essenti
electron
steric
requir
around
group
hand
antimicrobi
activ
prma
quit
sensit
chemic
modif
benzo
naphthacenequinon
group
methyl
group
substitut
posit
reduct
group
significantli
decreas
abolish
activ
posit
sole
site
modifi
without
lose
activ
deriv
activ
prma
result
indic
benzo
naphthacenequinon
group
prma
except
posit
play
pivot
role
antimicrobi
action
regard
disaccharid
group
prma
dxylos
compon
appar
essenti
prmb
lack
dxylos
group
indistinguish
prma
antimicrobi
activ
similarli
comparison
prma
benanomicin
b
prmc
suggest
methylamino
group
posit
substitu
littl
import
support
observ
activ
retain
introduct
variou
alkyl
acyl
group
onto
methylamino
group
contrast
antimicrobi
evalu
synthet
deriv
dfucos
larabinos
dgalactos
place
group
show
stereochemistri
posit
exist
methyl
group
posit
fairli
import
biolog
activ
prma
forego
studi
structureact
relationship
prma
oki
group
develop
semisynthet
deriv
show
augment
biolog
physicochem
properti
fig
prepar
reduct
nmethyl
display
vitro
vivo
antimicrobi
profil
tabl
xi
xii
similar
prma
greater
water
solubl
prma
mgml
prma
mgml
phosphatebuff
salin
contain
mm
cacl
mm
mgcl
ph
c
avail
sampl
handl
conveni
enabl
studi
mode
antimicrobi
action
prm
use
compound
first
foremost
step
carbohydr
bind
thoroughli
examin
earli
studi
prma
found
produc
insolubl
precipit
yeast
mannan
presenc
ca
ion
thu
quantit
analysi
precipit
ca
ion
methyl
admannopyranosid
meaman
initi
perform
molar
quantiti
ca
ion
meaman
precipit
determin
uvvis
spectrophotometri
atom
absorpt
spectrometri
phenolsulfur
acid
method
respect
molar
compon
ratio
ca
meaman
found
ratio
obtain
concentr
vari
dmannos
use
instead
meaman
form
precipit
indic
precipit
ca
ion
meaman
true
chemic
complex
simpl
mixtur
take
advantag
complexform
properti
carbohydr
specif
subsequ
evalu
shown
tabl
xiii
compound
produc
precipit
mebman
b
anom
pnitrophenyl
dmannopyranosid
paminophenyl
dmannopyranosid
dfructos
darabinos
dlyxos
well
dmannos
meaman
carbohydr
form
precipit
complex
format
carbohydr
also
confirm
uvvis
spectrophotometr
analysi
noteworthi
carbohydr
specif
quit
high
compound
abil
discrimin
dmannos
lmannos
oki
group
propos
carbohydr
arrang
similar
group
dmannos
fig
thu
bind
manner
dmannos
howev
lgalactos
lfucos
form
precipit
also
mimic
array
group
dmannos
studi
necessari
clarifi
issu
addit
howev
metal
specif
examin
uvvis
spectrophotometr
analysi
two
biolog
assay
yeastcel
absorpt
potassium
leakag
induct
test
result
collect
suggest
sr
cd
ion
ionic
radii
similar
ca
ion
ca
sr
cd
also
form
ternari
complex
mannan
sinc
discoveri
pradimicin
ctype
lectinlik
properti
interact
analysi
compound
ca
ion
dmannos
attempt
effort
understand
molecular
basi
carbohydr
recognit
pradimicin
oki
group
examin
ca
saltform
abil
prma
compound
deriv
fig
found
ester
deriv
form
ca
salt
wherea
prma
deriv
carboxyl
group
free
produc
ca
salt
prm
ca
ratio
although
hydroxyl
group
benzo
naphthacenequinon
group
also
potenti
bind
ca
ion
observ
suggest
carboxyl
group
prm
possibl
bind
site
ca
ion
hypothesi
partial
support
solut
nmr
analysi
format
ca
salt
signific
chang
chemic
shift
upon
addit
cacl
observ
proton
signal
posit
hand
proton
signal
posit
show
littl
chang
indic
ca
bind
site
near
ring
around
e
ring
prm
manbind
process
prm
investig
use
lee
cowork
group
perform
solidst
nmr
experi
use
solid
aggreg
prma
complex
meaman
first
stage
analysi
explor
role
ca
ion
bind
man
prma
alreadi
describ
cd
ion
act
surrog
ca
ion
bind
man
prm
accordingli
conduct
crosspolarizationmag
angl
spin
cpma
cdnmr
spectroscop
experi
solid
sampl
prma
cd
salt
ternari
prma
cd
meaman
complex
fig
cd
nmr
spectrum
prma
cd
salt
exhibit
broad
signal
around
ppm
similar
report
solid
cadmium
compound
contain
two
carboxyl
group
cd
oac
h
ppm
cd
cch
ch
co
ppm
result
indic
cd
ion
bind
carboxyl
group
prma
also
support
hypothesi
ca
ion
bridg
carboxyl
group
two
prm
molecul
produc
ca
salt
prm
ca
ratio
contrast
ternari
prma
cd
meaman
complex
exhibit
sharp
signal
ppm
markedli
shift
upfield
ppm
comparison
prma
cd
salt
ppm
suggest
occurr
chang
cd
coordin
upon
bind
meaman
prma
cd
salt
sinc
cd
signal
upfield
ppm
observ
cd
coordin
six
oxygen
ligand
reason
assum
hydroxyl
group
meaman
coordin
prma
cd
salt
realist
implic
result
prma
bind
least
one
molecul
man
ca
mediat
manner
carboxyl
group
solidst
cdnmr
spectroscop
analysi
suggest
possibl
one
bind
site
man
locat
proxim
carboxyl
group
prma
basi
assumpt
subsequ
analysi
direct
identifi
manbind
site
prma
sever
line
evid
suggest
prma
possess
two
bind
site
exhibit
differ
affin
man
although
undoubtedli
difficult
search
simultan
two
manbind
site
prma
success
prepar
aggreg
compos
sole
prma
ca
meaman
complex
manbind
site
stronger
affin
occupi
meaman
meaman
found
releas
weaker
bind
site
process
wash
aggreg
compos
prma
ca
meaman
complex
simpl
complex
biosynthet
cenrich
prma
mea
c
man
facilit
analysi
twodimension
dipolarassist
rotat
reson
stronger
bind
site
man
spectra
dipolar
interact
c
nuclei
locat
within
distanc
detect
cross
peak
permit
evalu
intermolecular
close
contact
prma
meaman
analys
detect
close
interact
dalanin
residu
prma
meaman
fig
close
contact
simultan
compat
man
locat
face
ring
dalanin
group
carbon
atom
suggest
caviti
consist
dalanin
group
abc
ring
stronger
bind
site
man
fig
similar
cpma
cdnmr
darr
experi
use
compound
confirm
mode
bind
ca
ion
man
nearli
ident
prma
base
result
solidst
nmr
analys
previou
structureact
relationship
studi
propos
model
man
bind
prma
fig
coordin
ca
hydrogen
bond
chp
interact
might
involv
interact
prma
man
particularli
interest
architectur
prma
natur
occur
lectin
mimic
seem
conceptu
similar
tripodtyp
lectin
mimic
fig
ring
provid
hydrophob
surfac
chp
interact
dalanin
anthraquinon
disaccharid
compon
serv
hydrophil
unit
although
investig
necessari
valid
model
studi
provid
import
step
toward
full
elucid
molecular
basi
recognit
man
prma
meaman
late
prma
benanomicin
b
discov
block
effect
hiv
infect
cellfre
well
celltocel
infect
system
vitro
subsequ
studi
oki
group
provid
evid
prma
inhibit
earli
step
hiv
infect
preincub
cell
hiv
c
follow
incub
prma
c
result
complet
inhibit
hiv
infect
wherea
prma
inhibit
infect
preincub
c
inhibitori
effect
observ
virus
treat
prma
wash
prior
infect
moreov
addit
mannan
ethylen
glycolbi
ether
n
n
n
n
tetraacet
acid
egta
prevent
inhibitori
effect
prma
thu
assum
prma
interfer
viral
fusion
process
bind
glycan
hiv
envelop
presenc
ca
ion
antivir
properti
prma
later
studi
detail
balzarini
cowork
prma
shown
inhibit
cytopath
effect
induc
although
ec
valu
lower
micromolar
rang
thu
quit
higher
natur
lectin
tabl
xiv
timeofdrugaddit
studi
demonstr
prma
well
mannosespecif
plant
lectin
hha
need
present
begin
viru
infect
fulli
suppress
infect
observ
support
assumpt
earli
event
infect
cycl
hiv
target
therapeut
intervent
prma
inhibit
hiv
entri
process
prma
interact
confirm
complet
loss
inhibitori
effect
prma
vsvgpseudotyp
lack
envelop
spr
analysi
reveal
prma
significantli
bound
ca
depend
manner
k
valu
mm
suggest
possibl
prma
inhibit
entri
viru
bind
high
mannosetyp
glycan
manner
similar
natur
lectin
accord
hypothesi
strain
select
increas
pressur
prma
found
contain
eight
differ
glycan
delet
high
mannosetyp
glycan
delet
similar
glycosyl
site
also
observ
mannosespecif
plant
lectin
hha
gna
cnv
thu
prma
act
lectin
term
glycan
recognit
antivir
activ
pattern
drug
resist
balzarini
group
also
examin
antivir
action
prm
watersolubl
deriv
prma
dglucos
group
instead
termin
dxylos
group
fig
prm
also
inhibit
cytopath
effect
show
ec
valu
similar
prma
tabl
xiv
bind
capac
prm
compar
prma
drug
resist
select
experi
use
prm
demonstr
prm
like
prma
select
drugresist
mutant
viru
strain
contain
delet
variou
nglycosyl
site
show
prm
well
prma
strong
prefer
bind
high
mannosetyp
glycan
subsequ
bewley
cowork
made
direct
observ
bind
prm
trisaccharid
aman
aman
man
use
saturationtransf
differ
std
nmr
moreov
prm
prma
found
inhibit
effici
dose
depend
bind
dcsignexpress
cell
indic
compound
prevent
viru
captur
dcsignexpress
cell
subsequ
transmiss
lymphocyt
prm
prma
also
investig
potenti
induc
chemokin
cytokin
contrast
prokaryot
mannosespecif
lectin
cvn
dramat
stimul
product
wide
rang
cytokin
chemokin
neither
compound
stimulatori
effect
chemocytokin
product
level
mononuclear
cell
peripher
blood
basi
uniqu
antivir
properti
prma
prm
well
lectin
balzarini
propos
novel
therapeut
concept
hiv
treatment
entir
differ
current
exist
therapeut
method
exposur
hiv
carbohydr
receptor
put
viru
dilemma
either
becom
elimin
host
kept
suppress
carbohydr
receptor
escap
pressur
carbohydr
receptor
mutat
glycosyl
site
therebi
becom
prone
neutral
elimin
immun
system
contrast
convent
strategi
design
drug
high
genet
barrier
possibl
delay
develop
drug
resist
propos
approach
make
use
viral
variabl
inher
viral
replic
gener
mutant
viru
strain
delet
glycosyl
site
moreov
therapeut
concept
uniqu
regard
use
concern
action
drug
chemotherapytrigg
immun
system
host
selfvaccin
administr
one
singl
drug
also
noteworthi
carbohydr
receptor
interact
target
molecul
nonstoichiometr
manner
exist
antihiv
drug
reversetranscriptas
inhibitor
proteas
inhibitor
bind
one
target
molecul
result
one
mutat
appear
target
usual
elicit
mark
degre
drug
resist
hand
sever
carbohydr
receptor
molecul
bind
one
molecul
bear
glycan
time
result
high
genet
barrier
hiv
overcom
obvious
effect
becom
signific
smaller
carbohydr
receptor
prma
prm
larger
number
molecul
simultan
bind
without
steric
hindranc
also
addit
advantag
protein
lectin
regard
chemic
stabil
product
although
antivir
activ
less
pronounc
lectin
lectin
mimic
possess
benefici
characterist
drug
develop
may
suitabl
candid
conceptu
novel
antihiv
drug
addit
antihiv
activ
prma
shown
possess
antivir
activ
hcv
coronavirus
simian
immunodefici
viru
prma
also
inhibit
entri
process
virus
bind
viral
envelopeassoci
glycan
therefor
prma
deriv
may
qualifi
potenti
antivir
drug
candid
infecti
diseas
deriv
virus
emerg
biolog
patholog
signific
carbohydr
increas
import
carbohydr
receptor
diagnost
therapeut
agent
well
research
tool
glycobiolog
number
effort
made
util
lectin
glycobiolog
research
yield
fruit
result
howev
applic
medicin
research
hamper
potenti
disadvantag
present
protein
natur
consequ
rapidli
grow
interest
small
molecul
carbohydratebind
properti
lectin
mimic
progress
studi
synthet
lectin
mimic
laid
excel
foundat
futur
develop
diagnost
therapeut
agent
base
carbohydr
recognit
boron
aciddepend
lectin
mimic
design
form
coval
bond
carbohydr
aqueou
media
sever
exampl
success
shown
act
possibl
sensor
biolog
import
biomark
sialyl
lewi
x
tf
antigen
especi
encourag
result
obtain
boron
aciddepend
lectin
mimic
peptid
backbon
noncoval
interact
hydrogen
bond
chp
interact
also
contribut
carbohydr
recognit
combin
coval
interact
boron
acid
compon
noncoval
interact
function
group
may
promis
strategi
design
new
gener
boron
aciddepend
lectin
mimic
act
diagnost
therapeut
agent
parallel
develop
intens
work
area
supramolecular
chemistri
gener
boron
acidindepend
lectin
mimic
reli
sole
noncoval
interact
carbohydr
number
tripodtyp
lectin
mimic
shown
bind
effect
carbohydr
organ
media
howev
exact
predict
bind
prefer
still
difficult
carbohydr
recognit
aqueou
media
mean
tripodtyp
architectur
remain
import
goal
futur
studi
meanwhil
cagetyp
lectin
mimic
success
demonstr
recognit
aqueou
solut
carbohydr
allequatori
substitut
mode
howev
present
strategi
exist
design
cagetyp
lectin
mimic
recogn
carbohydr
rapidli
evolv
comput
method
may
overcom
problem
initi
attempt
made
present
develop
synthet
lectin
mimic
antivir
antimicrobi
activ
natur
occur
lectin
mimic
pradimicin
benanomicin
becom
establish
promis
candid
therapeut
agent
novel
mode
action
express
antivir
antimicrobi
activ
bind
man
residu
glycan
viral
envelop
microbi
cell
wall
particularli
interest
natur
product
appear
constitut
highli
sophist
tripodtyp
lectin
mimic
possibl
provid
uniqu
guid
design
new
therapeut
lead
tripodtyp
architectur
advanc
field
research
novel
therapeut
drug
base
lectin
mimic
like
emerg
near
futur
